Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome

Frank Gonzalez, Lillie Chang, Theresa Horab, Frank Z. Stanczyk, Kent Crickard, Rogerio A. Lobo

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: To test the hypothesis that in women with polycystic ovary syndrome (PCOS), adrenal cytochrome P450c 17α activity is different after physiologic vs. pharmacologic ACTH stimulation and that ovarian activity promotes adrenal hyperactivity that is different after physiologic vs. pharmacologic ACTH stimulation. Design: Prospective controlled pilot study. Setting: Reproductive endocrinology unit of an academic medical center. Patient(s): Six women with PCOS who had adrenal hyperandrogenism were compared with four women with normal ovulation. Intervention(s): Adrenal dynamic blood sampling was performed before and after 6 months of GnRH agonist administration. Main Outcome Measure(s): Comparison of physiologic and pharmacologic ACTH-stimulated levels of progesterone, 17- hydroxyprogesterone, and androgens before and after ovarian steroid modulation. Result(s): In women with PCOS, exaggerated responses of androstenedione and 11β-hydroxyandrostenedione as well as elevated ratios of 17-hydroxyprogesterone to progesterone and of androstenedione to 17- hydroxyprogesterone after physiologic ACTH stimulation did not persist after GnRH-agonist administration. Three of the six women with PCOS had an increased response of androstenedione and a ratio of androstenedione to 17- hydroxyprogesterone that were >2 SD above the mean of those in the women with normal ovulation after pharmacologic ACTH stimulation; this finding persisted after GnRH-agonist administration. Conclusion(s): In women with PCOS, increases in adrenal androgen sensitivity after physiologic ACTH stimulation reflected in both arms of cytochrome P450c 17α activity may be influenced by ovarian activity. However, 17,20-lyase hyperactivity in a subset after pharmacologic ACTH stimulation may be an intrinsic adrenal disorder.

Original languageEnglish (US)
Pages (from-to)439-444
Number of pages6
JournalFertility and Sterility
Volume71
Issue number3
DOIs
StatePublished - Mar 1999
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Adrenocorticotropic Hormone
17-alpha-Hydroxyprogesterone
Steroids
Androstenedione
Gonadotropin-Releasing Hormone
Cytochromes
Ovulation
Androgens
Progesterone
Steroid 17-alpha-Hydroxylase
Hyperandrogenism
Ovulation Induction
Endocrinology
Outcome Assessment (Health Care)

Keywords

  • 17,20-lyase hyperactivity
  • Adrenal androgen sensitivity
  • Adrenal dynamic testing
  • GnRH agonist
  • Polycystic ovary syndrome

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome. / Gonzalez, Frank; Chang, Lillie; Horab, Theresa; Stanczyk, Frank Z.; Crickard, Kent; Lobo, Rogerio A.

In: Fertility and Sterility, Vol. 71, No. 3, 03.1999, p. 439-444.

Research output: Contribution to journalArticle

Gonzalez, Frank ; Chang, Lillie ; Horab, Theresa ; Stanczyk, Frank Z. ; Crickard, Kent ; Lobo, Rogerio A. / Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome. In: Fertility and Sterility. 1999 ; Vol. 71, No. 3. pp. 439-444.
@article{bbfb49dafe804b8eadb37119859d3525,
title = "Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome",
abstract = "Objective: To test the hypothesis that in women with polycystic ovary syndrome (PCOS), adrenal cytochrome P450c 17α activity is different after physiologic vs. pharmacologic ACTH stimulation and that ovarian activity promotes adrenal hyperactivity that is different after physiologic vs. pharmacologic ACTH stimulation. Design: Prospective controlled pilot study. Setting: Reproductive endocrinology unit of an academic medical center. Patient(s): Six women with PCOS who had adrenal hyperandrogenism were compared with four women with normal ovulation. Intervention(s): Adrenal dynamic blood sampling was performed before and after 6 months of GnRH agonist administration. Main Outcome Measure(s): Comparison of physiologic and pharmacologic ACTH-stimulated levels of progesterone, 17- hydroxyprogesterone, and androgens before and after ovarian steroid modulation. Result(s): In women with PCOS, exaggerated responses of androstenedione and 11β-hydroxyandrostenedione as well as elevated ratios of 17-hydroxyprogesterone to progesterone and of androstenedione to 17- hydroxyprogesterone after physiologic ACTH stimulation did not persist after GnRH-agonist administration. Three of the six women with PCOS had an increased response of androstenedione and a ratio of androstenedione to 17- hydroxyprogesterone that were >2 SD above the mean of those in the women with normal ovulation after pharmacologic ACTH stimulation; this finding persisted after GnRH-agonist administration. Conclusion(s): In women with PCOS, increases in adrenal androgen sensitivity after physiologic ACTH stimulation reflected in both arms of cytochrome P450c 17α activity may be influenced by ovarian activity. However, 17,20-lyase hyperactivity in a subset after pharmacologic ACTH stimulation may be an intrinsic adrenal disorder.",
keywords = "17,20-lyase hyperactivity, Adrenal androgen sensitivity, Adrenal dynamic testing, GnRH agonist, Polycystic ovary syndrome",
author = "Frank Gonzalez and Lillie Chang and Theresa Horab and Stanczyk, {Frank Z.} and Kent Crickard and Lobo, {Rogerio A.}",
year = "1999",
month = "3",
doi = "10.1016/S0015-0282(98)00469-5",
language = "English (US)",
volume = "71",
pages = "439--444",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome

AU - Gonzalez, Frank

AU - Chang, Lillie

AU - Horab, Theresa

AU - Stanczyk, Frank Z.

AU - Crickard, Kent

AU - Lobo, Rogerio A.

PY - 1999/3

Y1 - 1999/3

N2 - Objective: To test the hypothesis that in women with polycystic ovary syndrome (PCOS), adrenal cytochrome P450c 17α activity is different after physiologic vs. pharmacologic ACTH stimulation and that ovarian activity promotes adrenal hyperactivity that is different after physiologic vs. pharmacologic ACTH stimulation. Design: Prospective controlled pilot study. Setting: Reproductive endocrinology unit of an academic medical center. Patient(s): Six women with PCOS who had adrenal hyperandrogenism were compared with four women with normal ovulation. Intervention(s): Adrenal dynamic blood sampling was performed before and after 6 months of GnRH agonist administration. Main Outcome Measure(s): Comparison of physiologic and pharmacologic ACTH-stimulated levels of progesterone, 17- hydroxyprogesterone, and androgens before and after ovarian steroid modulation. Result(s): In women with PCOS, exaggerated responses of androstenedione and 11β-hydroxyandrostenedione as well as elevated ratios of 17-hydroxyprogesterone to progesterone and of androstenedione to 17- hydroxyprogesterone after physiologic ACTH stimulation did not persist after GnRH-agonist administration. Three of the six women with PCOS had an increased response of androstenedione and a ratio of androstenedione to 17- hydroxyprogesterone that were >2 SD above the mean of those in the women with normal ovulation after pharmacologic ACTH stimulation; this finding persisted after GnRH-agonist administration. Conclusion(s): In women with PCOS, increases in adrenal androgen sensitivity after physiologic ACTH stimulation reflected in both arms of cytochrome P450c 17α activity may be influenced by ovarian activity. However, 17,20-lyase hyperactivity in a subset after pharmacologic ACTH stimulation may be an intrinsic adrenal disorder.

AB - Objective: To test the hypothesis that in women with polycystic ovary syndrome (PCOS), adrenal cytochrome P450c 17α activity is different after physiologic vs. pharmacologic ACTH stimulation and that ovarian activity promotes adrenal hyperactivity that is different after physiologic vs. pharmacologic ACTH stimulation. Design: Prospective controlled pilot study. Setting: Reproductive endocrinology unit of an academic medical center. Patient(s): Six women with PCOS who had adrenal hyperandrogenism were compared with four women with normal ovulation. Intervention(s): Adrenal dynamic blood sampling was performed before and after 6 months of GnRH agonist administration. Main Outcome Measure(s): Comparison of physiologic and pharmacologic ACTH-stimulated levels of progesterone, 17- hydroxyprogesterone, and androgens before and after ovarian steroid modulation. Result(s): In women with PCOS, exaggerated responses of androstenedione and 11β-hydroxyandrostenedione as well as elevated ratios of 17-hydroxyprogesterone to progesterone and of androstenedione to 17- hydroxyprogesterone after physiologic ACTH stimulation did not persist after GnRH-agonist administration. Three of the six women with PCOS had an increased response of androstenedione and a ratio of androstenedione to 17- hydroxyprogesterone that were >2 SD above the mean of those in the women with normal ovulation after pharmacologic ACTH stimulation; this finding persisted after GnRH-agonist administration. Conclusion(s): In women with PCOS, increases in adrenal androgen sensitivity after physiologic ACTH stimulation reflected in both arms of cytochrome P450c 17α activity may be influenced by ovarian activity. However, 17,20-lyase hyperactivity in a subset after pharmacologic ACTH stimulation may be an intrinsic adrenal disorder.

KW - 17,20-lyase hyperactivity

KW - Adrenal androgen sensitivity

KW - Adrenal dynamic testing

KW - GnRH agonist

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=0032959034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032959034&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(98)00469-5

DO - 10.1016/S0015-0282(98)00469-5

M3 - Article

C2 - 10065779

AN - SCOPUS:0032959034

VL - 71

SP - 439

EP - 444

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 3

ER -